Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Arnold

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
ACS Combinatorial Science|December 21, 2019
Oxidative Cyclization Approach to Benzimidazole LibrariesEric P Arnold, Prolay K Mondal, Daniel C Schmitt
The Journal of Organic Chemistry|May 16, 2009
Diastereoselective synthesis of 2,3,6-trisubstituted piperidinesJohn M Humphrey, Eric P Arnold, Thomas A Chappie, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2009
Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonistsChristopher J O'Donnell, Langu Peng, Brian T O'Neill, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2005
In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisineJotham W Coe, Michael G Vetelino, Crystal G Bashore, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2005
3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessationJotham W Coe, Paige R Brooks, Michael C Wirtz, et al.
Journal of Medicinal Chemistry|February 17, 2025
Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 AntagonistsBrian S Gerstenberger, Ray Unwalla, Kathleen A Farley, et al.
Journal of Medicinal Chemistry|May 13, 2005
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessationJotham W Coe, Paige R Brooks, Michael G Vetelino, et al.
Journal of Medicinal Chemistry|August 14, 2020
Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune DiseasesBrian S Gerstenberger, Catherine Ambler, Eric P Arnold, et al.
Journal of Medicinal Chemistry|June 3, 2017
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A InhibitorChristopher J Helal, Eric P Arnold, Tracey L Boyden, et al.
Journal of Medicinal Chemistry|January 4, 2018
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune DiseasesMichael L Vazquez, Neelu Kaila, Joseph W Strohbach, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
ACS Combinatorial Science|December 21, 2019
Oxidative Cyclization Approach to Benzimidazole LibrariesEric P Arnold, Prolay K Mondal, Daniel C Schmitt
The Journal of Organic Chemistry|May 16, 2009
Diastereoselective synthesis of 2,3,6-trisubstituted piperidinesJohn M Humphrey, Eric P Arnold, Thomas A Chappie, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2009
Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonistsChristopher J O'Donnell, Langu Peng, Brian T O'Neill, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2005
In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisineJotham W Coe, Michael G Vetelino, Crystal G Bashore, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2005
3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessationJotham W Coe, Paige R Brooks, Michael C Wirtz, et al.
Journal of Medicinal Chemistry|February 17, 2025
Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 AntagonistsBrian S Gerstenberger, Ray Unwalla, Kathleen A Farley, et al.
Journal of Medicinal Chemistry|May 13, 2005
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessationJotham W Coe, Paige R Brooks, Michael G Vetelino, et al.
Journal of Medicinal Chemistry|August 14, 2020
Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune DiseasesBrian S Gerstenberger, Catherine Ambler, Eric P Arnold, et al.
Journal of Medicinal Chemistry|June 3, 2017
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A InhibitorChristopher J Helal, Eric P Arnold, Tracey L Boyden, et al.
Journal of Medicinal Chemistry|January 4, 2018
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune DiseasesMichael L Vazquez, Neelu Kaila, Joseph W Strohbach, et al.
Pageof 2